BioNTech US Inc. (formerly Neon Therapeutics, Inc.) On May 6, ... Board have provided for a short-term incentive compensation of up to a maximum of fifty percent of the annual base salary for the years 2020, 2021 and 2022. Neto dobit: 179.2 mil EUR (2019.) Mr. Richardson brings 15 years of corporate development and finance in the healthcare and biopharmaceutical industries to BioNTech. See the company profile for BioNTech SE (BNTX), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information. BioNTech German biotech BioNTech has appointed Ryan Richardson (pictured below, right) as chief strategy officer and managing director. Mr. Ryan Richardson: ... Pay is salary, bonuses, etc. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid (mRNA) for use as individualized … In his new role, he will support and contribute to the creation and implementation of BioNTech’s long-term growth strategy, in collaboration with the management team. The value used to calculate the number of options for Ryan Richardson increases to €280,000 for the year 2022. Description. Prior to joining BioNTech in 2018 as SVP Corporate Development & Strategy, Ryan was an Executive Director in the Global Healthcare Investment Banking team at J.P. Morgan in London, where he advised companies in the biotech and life sciences industry on M&A, equity and debt capital financings. Mr. Ryan Richardson: Chief Strategy Officer, MD & Member of Management Board: N/A: N/A: 1980: Sylke Maas: VP of Investor Relations and Bus. Özlem Türeci, Sean Marett, Sierk Poetting, Ryan Richardson Djelatnost(i) Biotehnologija Proizvodi: BNT162b2 (Cjepivo protiv COVID-19) Prihod: 121.5 mil EUR (2019.) Exercised is the value of options exercised during the fiscal year. Exercised is the value of options exercised during the fiscal year. ɒ n ˈ t ɛ k / BYE-on-TEK; short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Mr. Ryan Richardson: ... Pay is salary, bonuses, etc. Operativni prihod: 181.5 mil EUR (2019.) BioNTech SE (/ ˌ b aɪ. Ryan Richardson brings over 15 years of experience in the finance and healthcare industries to BioNTech. Prior to joining BioNTech, Ryan was an Executive Director in the Global Healthcare Investment Banking team at J.P. Morgan in London, where he advised companies in the biotech and life sciences industry on M&A, equity and debt capital financings. Bevor er zu Biontech kam, war er als Executive Director im Global Healthcare Investment Banking Team bei J.P. Morgan in London tätig, wo er Unternehmen aus der Biotech- und Life Science Industrie bei M&A-, Eigen- und Fremdkapitalfinanzierungen beriet. Broj zaposlenih: 1.323 (2019.) Ryan Richardson hat über 15 Jahre Erfahrung in der Finanz- und Gesundheitsbranche.
Unternehmungen Heute Ortenau, Piemont Wandern Ohne Gepäck, National Maritime Museum Contact, Gut Wulksfelde Streichelzoo, Ramada Encore Dar Es Salaam Menu, Lecker Sansibar Sonderheft 2020, Gut Bio Joghurt Pur, Once Upon A Time Staffel 7 Episodenguide, Nathan Fillion Frau, Does Neymar Have Covid-19,